← Open Payments lookup

KRISTEN STREETT: Open Payments

NPI 1710615174 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,671 in 153 payments from 22 companies in 2025. Trend: 2023 $776 · 2024 $1,874 · 2025 $3,671

Food & beverage: $3,671
CompanyPaymentsAmount
ABBVIE INC.26$583
Janssen Biotech, Inc.19$535
Madrigal Pharmaceuticals18$448
Takeda Pharmaceuticals U.S.A., Inc.15$403
GENZYME CORPORATION9$262
Ipsen Biopharmaceuticals, Inc7$205
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$204
PFIZER INC.9$170
Gilead Sciences, Inc.6$123
Aimmune Therapeutics, Inc.5$119

Products named: TREMFYA, REZDIFFRA, DUPIXENT, ENTYVIO, IQIRVO, XIFAXAN, CREON, RINVOQ.

Industry payments across MD — which companies pay providers there.